Filing Flows

Filing Flows › Camp4 Therapeutics (CAMP) › Next earnings date

Camp4 Therapeutics (CAMP) earnings: beat the estimate

Camp4 Therapeutics (CAMP) reported on Nov 5, 2026 and beat the EPS estimate: −$0.17 against −$0.22 (+24.2%). Revenue was $1.9M for Q3 2026, +139% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result+24.2% vs estimate
Beat rate40%

The last report

Camp4 Therapeutics reported revenue of $1.9M for the third quarter 2026 (+139% Y/Y), net loss $29.0M. How it makes money → · Every quarter →

Camp4 Therapeutics: EPS against the estimate, last 5 reportsCamp4 Therapeutics: EPS against the estimate, last 5 reportsEstimateReported−$0.48−$0.54Nov 25−$0.29−$0.23Mar 26−$0.21−$0.21May 26−$0.21−$0.22Aug 26−$0.22−$0.17Nov 26
Latest (Nov 26): Estimate −$0.22, Reported −$0.17.

Camp4 Therapeutics' latest quarter

Camp4 Therapeutics, Q3 2026: revenue $1.9M (+139% year over year), operating margin -738.8%, net loss $29.0M, operating cash flow −$8.2M. The chart follows the revenue to costs, profit and cash.

Questions

Did Camp4 Therapeutics beat earnings?

Camp4 Therapeutics (CAMP) reported on Nov 5, 2026 and beat the EPS estimate: −$0.17 against −$0.22 (+24.2%).

When does CAMP report earnings?

The next date is not set yet.

Does Camp4 Therapeutics usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.